Table 1.
Clinical characteristics of patients with and without elevated cTnI.
| Variable | Troponin elevation | P valueα | |
|---|---|---|---|
| Yes (n = 45) | No (n = 194) | ||
| Age (year) median* (Min–Max)** | 78 (R: 42–98) | 73 (R: 24–93) | 0.08 |
| NIHSS at hospitalization median (Min–Max) | 13 (R: 1–19) | 12 (R: 0–19) | 0.34 |
| NIHSS at discharge median (Min–Max) | 12 (R: 0–36) | 11 (R: 1–36) | 0.03 |
| mRS at hospitalization median (Min–Max) | 4 (R: 1–5) | 4 (R: 0–12) | 0.09 |
| mRS at discharge median (Min–Max) | 4 (R: 1–6) | 4 (R: 0–11) | 0.02 |
| Duration of hospitalization (day) median (Min–Max) | 7 (R: 1–39) | 6 (R: 1–34) | 0.95 |
| Ischemic stroke patients (n) | |||
| Anterior circulation | 32 | 123 | |
| Posterior circulation | 8 | 49 | 0.55 |
| Hemorrhagic stroke patients (n) | 5 | 22 | |
| Insular cortex involvement | 29 | 70 | 0.001 β |
| Gender (female/male) | 28/17 | 98/96 | 0.15 |
*Median, **range (Min–Max), αMann-Whitney U test, βSpearman correlation.